A multicenter, randomized, double-blind, placebo-controlled trial of thalidomide plus dexamethasone versus dexamethasone alone as initial therapy for newly diagnosed multiple myeloma.

被引：0
|
作者：
Rajkumar, S. V.
Hussein, M.
Catalano, J.
Jedrzejcak, W.
Sirkovich, S.
Olesnyckyj, M.
Yu, Z.
Knight, R.
Zeldis, J. B.
Blade, J.
机构：
[1] Mayo Clin, Rochester, MN USA
[2] Cleveland Clin, Cleveland, OH 44106 USA
[3] Frankston Hosp, Frankston, Australia
[4] Med Acad Warsaw, Warsaw, Poland
[5] UAMS, Kiev Inst Oncol, Kiev, Ukraine
[6] Celgene Corp, Summit, NJ USA
[7] Hosp Clin Barcelona, Barcelona, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2006年 / 24卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：426S / 426S
页数：1
相关论文
共 50 条
  • [31] RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 STUDY OF PANOBINOSTAT OR PLACEBO PLUS BORTEZOMIB AND DEXAMETHASONE IN RELAPSED OR RELAPSED AND REFRACTORY MULTIPLE MYELOMA (PANORAMA 1)
    San-Miguel, J.
    Hungria, V. T.
    Yoon, S. S.
    Beksac, M.
    Dimopoulos, M. A.
    Elghandour, A.
    Jedrzejczak, W. W.
    Guenther, A.
    Nakorn, T. Na
    Siritanaratkul, N.
    Schlossman, R. L.
    Hou, J.
    Moreau, P.
    Lonial, S.
    Lee, J. H.
    Einsele, H.
    Salwender, H.
    Sopala, M.
    Bengoudifa, B. R.
    Corrado, C.
    Binlich, F.
    Richardson, P.
    HAEMATOLOGICA, 2014, 99 : 219 - 220
  • [32] Doxorubicin and dexamethasone (AD) followed by thalidomide and dexamethasone (TD) as initial therapy for symptomatic patients with multiple myeloma.
    Comenzo, RL
    Hassoun, H
    Reich, L
    Klimek, V
    Kewalramani, T
    Dhodapkar, M
    Drake, L
    Hedvat, C
    Teruya-Feldstein, J
    Fleisher, M
    Filippa, DA
    Nimer, SD
    BLOOD, 2003, 102 (11) : 450A - 451A
  • [33] Combination therapy with lenalidomide plus dexamethasone (Rev/Dex) for newly diagnosed myeloma.
    Rajkumar, SV
    Hayman, S
    Lacy, MQ
    Dispenzieri, A
    Geyer, SM
    Kabat, B
    Zeldenrust, SR
    Kumar, S
    Greipp, PR
    Fonseca, R
    Lust, JA
    Russell, SJ
    Kyle, RA
    Witzig, TE
    Gertz, MA
    BLOOD, 2005, 106 (11) : 230A - 231A
  • [34] Circularly permuted TRAIL (CPT) combined with Thalidomide and Dexamethasone in patients with relapsed/refractory Multiple Myeloma: a randomized, double-blind, placebo-controlled phase 3 study
    Chen, Wenming
    Xia, Zhongjun
    Fang, Baijun
    Fu, Chengcheng
    Li, Wei
    Yang, Linhua
    Ke, Xiaoyan
    Jiang, Hua
    Weng, Jianyu
    Liu, Li
    Zhao, Yaozhong
    Zhang, Xuejun
    Liu, Aichun
    Huang, Zhongxia
    Shi, Qingzhi
    Gao, Yuhuan
    Chen, Xiequn
    Pan, Ling
    Cai, Zhen
    Wang, Zhao
    Wang, Yafei
    Zhang, Yizhuo
    Fan, Yaqun
    Hou, Ming
    Yang, Shifang
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S143 - S143
  • [35] Thalidomide, clarithromycin, lenalidomide and dexamethasone therapy in newly diagnosed, symptomatic multiple myeloma
    Mark, Tomer M.
    Bowman, Isaac A.
    Rossi, Adriana C.
    Shah, Manan
    Rodriguez, Melissa
    Quinn, Ryann
    Pearse, Roger N.
    Zafar, Faiza
    Pekle, Karen
    Jayabalan, David
    Ely, Scott
    Coleman, Morton
    Chen-Kiang, Selina
    Niesvizky, Ruben
    LEUKEMIA & LYMPHOMA, 2014, 55 (12) : 2842 - 2849
  • [36] Higher single dose of bortezomib plus thalidomide and dexamethasone is a promising therapy for newly diagnosed multiple myeloma
    Xu, Peipei
    Zhou, Rongfu
    Xu, Jingyan
    Ouyang, Jian
    Shao, Xiaoyan
    Chen, Bing
    TRANSLATIONAL CANCER RESEARCH, 2019, 8 (05) : 2099 - 2106
  • [37] Coagulation profiles and thromboembolic events of bortezomib plus thalidomide and dexamethasone therapy in newly diagnosed multiple myeloma
    Shen, Yunfeng
    Zhou, Xin
    Wang, Zhi
    Yang, Guohua
    Jiang, Yuanqiang
    Sun, Chao
    Wang, Jing
    Tong, Yi
    Guo, Hongfeng
    LEUKEMIA RESEARCH, 2011, 35 (02) : 147 - 151
  • [38] Effect of thrombotic events on overall survival in patients with newly diagnosed myeloma: Analysis from a randomized phase III trial of thalidomide plus dexamethasone versus dexamethasone in newly diagnosed multiple myeloma (E1A00)
    Kumar, Shaji
    Zhang, Lijun
    Greipp, Philip R.
    Rajkumar, S. Vincent
    BLOOD, 2007, 110 (11) : 803A - 803A
  • [39] Cranberry versus placebo in the prevention of urinary infections in multiple sclerosis: a multicenter, randomized, placebo-controlled, double-blind trial
    Gallien, Philippe
    Amarenco, Gerard
    Benoit, Nicolas
    Bonniaud, Veronique
    Donze, Cecile
    Kerdraon, Jacques
    de Seze, Marianne
    Denys, Pierre
    Renault, Alain
    Naudet, Florian
    Reymann, Jean Michel
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 (09) : 1252 - 1259
  • [40] A multicenter, randomized, double-blind, placebo-controlled trial of influenza immunization in multiple sclerosis
    Miller, AE
    Morgante, LA
    Buchwald, LY
    Coyle, PK
    Krupp, LB
    Doscher, CA
    Lublin, FD
    Knobler, RL
    Trantas, F
    Kelley, L
    Smith, CR
    LaRocca, N
    Lopez, S
    NEUROLOGY, 1997, 48 (02) : 312 - 314
12345